| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. | Endocrinology | 2007 | 1.96 |
| 2 | Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. | J Med Chem | 2012 | 1.19 |
| 3 | PDE-10A inhibitors as insulin secretagogues. | Bioorg Med Chem Lett | 2007 | 0.90 |
| 4 | Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes. | J Endocrinol | 2007 | 0.83 |
| 5 | Engineering of a VPAC2 receptor peptide agonist to impart dipeptidyl peptidase IV stability and enhance in vivo glucose disposal. | J Med Chem | 2006 | 0.79 |
| 6 | The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus. | Bioorg Med Chem Lett | 2012 | 0.77 |